Skip to main content

Table 1 Demographics of SLE and healthy controls

From: Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity

  SLE patients (n= 42) Healthy donors (n= 25)
Age (years) 27.4 ± 10.12 (13 to 45) 25.2 ± 9.58 (20 to 42)
Sex(female/male) 39/3 23/2
Disease duration(years) 2.45 ± 2.67 -
Alopecia n (%) 16 (38.1) -
Mucosal ulcer n (%) 10 (23.8) -
Malar rash n (%) 26 (61.9) -
Arthritis n (%) 29 (69.1) -
Current renal disease n (%) 25 (59.5) -
Pleuritis n (%) 2 (4.8) -
Fever n (%) 10 (23.8) -
Neurological disorder n (%) 2 (4.8) -
Anemia n (%) 12 (28.6) -
Thrombocytopenia n (%) 8 (19) -
Leukopenia n (%) 22 (52.4) -
ds-DNA n (%) 26 (61.9) -
AnuA n (%) 20 (47.6) -
Smith n (%) 10 (23.8) -
AHA n (%) 20 (47.6) -
rRNP n (%) 8 (19)  
ESR 34.05 ± 26.79 -
CRP 5.31 ± 6.44 -
Low C3 n (%) 26 (61.9) -
Low C4 n (%) 22 (52.4) -
24-hour urine protein n (%) 22 (52.4) (> 0.5 g/24 h) -
SLEDAI 4 to 30 (13.9 ± 7.12) -
  1. Except where otherwise indicated, values are expressed as mean ± standard deviation. There were no significant differences between patients with SLE and healthy donors in terms of age and sex. AHA, anti-histone antibody; AnuA, anti-nucleosome antibody; C3, complement 3; C4, complement 4; CRP, C-reactive protein; ds-DNA, anti-double stranded DNA antibody; ESR, erythrocyte sedimentation rate; rRNP, anti-ribosome ribonucleoprotein antibody; SLE, systemic lupus erythematosus; SLEDAI, SLE disease activity index; Smith, anti-smith-antibody.